Clinical Research Directory
Browse clinical research sites, groups, and studies.
Trial of Modifications to Radical Prostatectomy
Sponsor: Memorial Sloan Kettering Cancer Center
Summary
This trial will evaluate whether the following aspect of surgical technique influence outcome: Lymph node dissection. In some patients, scans taken before surgery show that a lymph node has cancer. Surgeons make sure to remove those affect lymph nodes and all other lymph nodes in the area. However, it is not known whether removing lymph nodes helps prostate cancer patients whose scans do not show positive nodes. In this study, patients with clear scans will either receive a lymph node dissection or not."
Official title: A Randomized Trial of Modifications to Radical Prostatectomy
Key Details
Gender
MALE
Age Range
21 Years - Any
Study Type
INTERVENTIONAL
Enrollment
3204
Start Date
2011-07
Completion Date
2026-07
Last Updated
2025-08-14
Healthy Volunteers
No
Conditions
Interventions
Lymph node template
Inclusion of the external iliac, hypogastric and obturator fossa nodal groups in the template undergoing a Radical Prostatectomy. Modifying the template for lymph node dissection may lead to removal of additional affected nodes, reducing the chance of recurrence. .No lymph nodes will be removed in patients randomized to the no PLND arm.
Transverse versus vertical closure
Transverse versus vertical closure of the port site incision
antibiotic prophylaxis
One vs. three days of antibiotic prophylaxis at catheter removal
Hemostatic Agent
For the patients randomized to routine indwelling HA agent use, the operating surgeon may choose to use either Surgicel™, Surgicel SNoW™, Arista™, FloSeal or surgeon's choice HA directed at the prostatic fossa, ligated dorsal vein complex, or neurovascular bundles. Because there is no standard HA or method of application, the surgeon will apply the HA according to the surgeon's experience and document both the HA used, and the location applied in the operative report. For patients randomized to no routine indwelling HA use, surgeons will only apply a HA if they are unable to achieve hemostasis using traditional means or feel it would be unsafe to complete the operation without using a HA for additional hemostasis. Providers in either arm may use HA as needed provided the intention is not to leave the HA indwelling.
Locations (5)
Memorial Sloan Kettering Cancer Center at Basking Ridge
Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Bergen (Consent Only)
Montvale, New Jersey, United States
Memorial Sloan Kettering Westchester
Harrison, New York, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Memorial Sloan Kettering Cancer Center @ Nassau (Consent only)
Uniondale, New York, United States